G, D., & P, M. (2018). Ertugliflozin: A sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes. Dove Medical Press.
Chicago Style (17th ed.) CitationG, Derosa, and Maffioli P. Ertugliflozin: A Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes. Dove Medical Press, 2018.
MLA (8th ed.) CitationG, Derosa, and Maffioli P. Ertugliflozin: A Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes. Dove Medical Press, 2018.
Warning: These citations may not always be 100% accurate.